Metformin Associated with Reduced Mortality in CKD, CHF, and CLD

annals.org January 3, 2017

metformin-associated-with-reduced-mortality-in-ckd-chf-and-cld

Metformin is currently the suggested initial treatment for type 2 diabetes mellitus in the United States. In the past, the U.S. Food and Drug Administration (FDA) did not recommend metformin for patients with chronic kidney disease (CKD), congestive heart failure (CHF), and/or chronic liver disease (CLD) with hepatic impairment.

diabetes FDA kidneys liver study treatment

Fluid Personalization and Vasopressor Decisions in Early Sepsis Management

Fluid Personalization and Vasopressor Decisions in Early Sepsis Management

AKI Risk Factors in ICU Patients Using Colistin

AKI Risk Factors in ICU Patients Using Colistin

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Omadacycline Treatment of Severe Pneumonia Complicated with ARDS During COVID-19

Omadacycline Treatment of Severe Pneumonia Complicated with ARDS During COVID-19

Pocket Medicine: The Massachusetts General Hospital Handbook of Internal Medicine

Sepsis and Septic Shock: An Issue of Critical Care Clinics

Intensive Care Unit Telemedicine, An Issue of Critical Care Clinics

Interventional Critical Care: A Manual for Advanced Care Practitioners

Damage Control Resuscitation: Identification and Treatment of Life-Threatening Hemorrhage

Priorities in Critical Care Nursing

The Danger Within Us: America’s Untested, Unregulated Medical Device Industry and One Man’s Battle to Survive It

Sepsis Management: PIRO and MODS

Extracorporeal Life Support for Adults

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Critical Care: A New Nurse Faces Death, Life, and Everything in Between